MedTrace Logo

Efficacy and Safety of High Absorption Pad in Split-thickness Skin Graft Donor Site Wound

NCT04299126 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2020-03-06

No results posted yet for this study

Summary

High absorption pad for blood and pus with natural antimicrobial agent or gauze dressing impregnated with paraffin, containing 0.5% chlorhexidine acetate (Bactigras) will be randomly covered on half of split-thickness skin graft donor site wound. The another will be cover on another half of split-thickness skin graft donor site wound. Then, they will be covered with gauzes and bandage. Time to wound healing, amounts of covered dressing gauzes, signs of infection, pain score, erythema index, melanin index, trans epidermal water loss index, and adverse events will be evaluated.

Conditions

  • Disorder of Skin Donor Site

Interventions

DEVICE

high absorption pad for blood and pus

High absorption pad for blood and pus will be covered on half of split-thickness skin graft donor site wound until the wound has healed.

DEVICE

commercial wound dressing

Commercial wound dressing will be covered on half of split-thickness skin graft donor site wound until the wound has healed.

Sponsors & Collaborators

  • Chulalongkorn University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-05
Primary Completion
2021-01-30
Completion
2021-02-15

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04299126 on ClinicalTrials.gov